Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
Top Cited Papers
- 15 July 2020
- journal article
- research article
- Published by Elsevier
- Vol. 59 (4) , 493-503
- https://doi.org/10.1016/j.amepre.2020.06.011
Abstract
No abstract availableAll Related Versions
Funding Information
- Agency for Healthcare Research and Quality
- United States Agency for International Development
- National Institute of General Medical Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
This publication has 9 references indexed in Scilit:
- The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United StatesHealth Affairs, 2020
- The COVID-19 vaccine development landscapeNature Reviews Drug Discovery, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaNew England Journal of Medicine, 2020
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in GermanyNew England Journal of Medicine, 2020
- Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019‐nCoVJournal of Evidence-Based Medicine, 2020
- Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreakPublished by Elsevier ,2020
- A systems approach to vaccine decision makingVaccine, 2017
- Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstaclesVaccine, 2010
- Editorial Commentary:Digital Decision Making: Computer Models and Antibiotic Prescribing in the Twenty‐First CenturyClinical Infectious Diseases, 2008